{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:27:41Z","timestamp":1790346461004,"version":"4.1.0"},"reference-count":41,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Ovarian Cancer Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The aim of this survey was to increase the knowledge on the characteristics and health concerns of long-term survivors (LTS; survival &gt; 5 years) after ovarian cancer in order to tailor follow-up care. This international survey was initiated by the NOGGO and was made available to members of ENGOT and GCIG. The survey is anonymous and consists of 68 questions regarding sociodemographic, medical (cancer) history, health concerns including distress, long-term side effects, and lifestyle. For this analysis, 1044 LTS from 14 countries were recruited. In total, 58% were diagnosed with FIGO stage III\/IV ovarian cancer and 43.4% developed recurrent disease, while 26.0% were receiving cancer treatment at the time of filling in the survey. LTS who survived 5\u201310 years self-estimated their health status as being significantly worse than LTS who survived more than 10 years (p = 0.034), whereas distress also remained high 10 years after cancer diagnosis. Almost half of the cohort (46.1%) reported still having symptoms, which were mainly lymphedema (37.7%), fatigue (23.9%), pain (21.6%), polyneuropathy (16.9%), gastrointestinal problems (16.6%), and memory problems (15.5%). Almost all patients (94.2%) regularly received follow-up care. Specialized survivorship care with a focus on long-term side effects, lifestyle, and prevention should be offered beyond the typical five years of follow-up care.<\/jats:p>","DOI":"10.3390\/cancers15225428","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T10:57:46Z","timestamp":1700045866000},"page":"5428","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors\u2014Results of Expression VI\u2013Carolin Meets HANNA\u2013Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8617-5535","authenticated-orcid":false,"given":"Hannah","family":"Woopen","sequence":"first","affiliation":[{"name":"Department of Gynecology with Center for Oncological Surgery, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"North-Eastern German Society for Gynecological Oncology (NOGGO), 13359 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Keller","sequence":"additional","affiliation":[{"name":"North-Eastern German Society for Gynecological Oncology (NOGGO), 13359 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-6919","authenticated-orcid":false,"given":"Dario","family":"Zocholl","sequence":"additional","affiliation":[{"name":"North-Eastern German Society for Gynecological Oncology (NOGGO), 13359 Berlin, Germany"},{"name":"Institute of Biometry and Clinical Epidemiology, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Mittelstadt","sequence":"additional","affiliation":[{"name":"North-Eastern German Society for Gynecological Oncology (NOGGO), 13359 Berlin, Germany"},{"name":"Department of Women\u2019s Health, University Hospital T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Pilar","family":"Barretina-Ginesta","sequence":"additional","affiliation":[{"name":"Institut Catal\u00e0 d\u2019Oncologia, Medical Oncology Department, 17007 Girona, Spain"},{"name":"Precision Oncology Group, Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Girona, 17007 Girona, Spain"},{"name":"Medical Sciences Department, Universitat de Girona, 17003 Girona, Spain"},{"name":"Grupo Espa\u00f1ol de Investigaci\u00f3n en C\u00e1ncer de Ovario (GEICO), 28003 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Heinzelmann-Schwarz","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecologic Oncology, University Hospital of Basel, 4056 Basel, Switzerland"},{"name":"Swiss GO Trial Group (Swiss-GO), 4031 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Lafleur","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Ordensklinikum Barmherzige Schwestern Linz, 4020 Linz, Austria"},{"name":"Arbeitsgemeinschaft Gynaekologische Onkologie Austria (AGO Austria), 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5896-4158","authenticated-orcid":false,"given":"Roman","family":"Koci\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, Obstetrics and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, 12 108 Prague, Czech Republic"},{"name":"General University Hospital in Prague, 12 808 Prague, Czech Republic"},{"name":"Central and Eastern European Gynecologic Oncology Group (CEEGOG), 128 51 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Baum","sequence":"additional","affiliation":[{"name":"Department of Gynecology with Center for Oncological Surgery, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"North-Eastern German Society for Gynecological Oncology (NOGGO), 13359 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Krabisch","sequence":"additional","affiliation":[{"name":"North-Eastern German Society for Gynecological Oncology (NOGGO), 13359 Berlin, Germany"},{"name":"Department of Gynaecology and Obstetrics, Klinikum Chemnitz, 09116 Chemnitz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-5883","authenticated-orcid":false,"given":"Patriciu","family":"Achimas-Cadariu","sequence":"additional","affiliation":[{"name":"Institute of Oncology Prof. Dr. I. Chiricuta Cluj-Napoca, University of Medicine and Pharmacy Iuliu Hatieganu, 400015 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Vardar","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Cukurova University, 01250 Adana, Turkey"},{"name":"Turkish Society of Gynecologic Oncology (TRSGO), Ovecler, 06450 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7589-8981","authenticated-orcid":false,"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[{"name":"Division of Gynaecological Oncology, Leuven Cancer Institute, University Hospitals Leuven, 3000 Leuven, Belgium"},{"name":"Belgium and Luxembourg Gynaecological Oncology Group (BGOG), 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-7532","authenticated-orcid":false,"given":"Sara","family":"Nasser","sequence":"additional","affiliation":[{"name":"Department of Gynecology with Center for Oncological Surgery, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"Pan-Arabian Research Society of Gynecological Oncology (PARSGO), 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Link","sequence":"additional","affiliation":[{"name":"North-Eastern German Society for Gynecological Oncology (NOGGO), 13359 Berlin, Germany"},{"name":"Department of Gynecology and Obstetrics, Technische Universit\u00e4t Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-5355","authenticated-orcid":false,"given":"Marta","family":"Gil-Martin","sequence":"additional","affiliation":[{"name":"Grupo Espa\u00f1ol de Investigaci\u00f3n en C\u00e1ncer de Ovario (GEICO), 28003 Madrid, Spain"},{"name":"Catalan Institute of Oncology\u2014IDIBELL, L\u2019Hospitalet-Barcelona, 08908 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-6572","authenticated-orcid":false,"given":"Tibor A.","family":"Zwimpfer","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecologic Oncology, University Hospital of Basel, 4056 Basel, Switzerland"},{"name":"Swiss GO Trial Group (Swiss-GO), 4031 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9572-9114","authenticated-orcid":false,"given":"Katharina","family":"Leitner","sequence":"additional","affiliation":[{"name":"Arbeitsgemeinschaft Gynaekologische Onkologie Austria (AGO Austria), 6020 Innsbruck, Austria"},{"name":"Department of Obstetrics and Gynecology, Innsbruck Medical University, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-0311","authenticated-orcid":false,"given":"Marcin","family":"Jedryka","sequence":"additional","affiliation":[{"name":"Central and Eastern European Gynecologic Oncology Group (CEEGOG), 128 51 Prague, Czech Republic"},{"name":"Gynecological Oncology Department, Wroclaw Medical University, 50-367 Wroclaw, Poland"},{"name":"Oncological Gynecology Department, Lower Silesian Oncology, Pulmonology and Hematology Center, 53-413 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Boxler","sequence":"additional","affiliation":[{"name":"Frauenklinik F\u00fcrth, 90766 F\u00fcrth, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Ioana","family":"Braicu","sequence":"additional","affiliation":[{"name":"Department of Gynecology with Center for Oncological Surgery, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"North-Eastern German Society for Gynecological Oncology (NOGGO), 13359 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-6623","authenticated-orcid":false,"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[{"name":"Department of Gynecology with Center for Oncological Surgery, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, 13353 Berlin, Germany"},{"name":"North-Eastern German Society for Gynecological Oncology (NOGGO), 13359 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.22.01549","article-title":"Overall Survival with Maintenance Olaparib at a 7-Year Follow-Up in Patients with Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1\/GOG 3004 Trial","volume":"41","author":"DiSilvestro","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.3390\/cancers13225756","article-title":"Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?","volume":"13","author":"DiSilvestro","year":"2021","journal-title":"Cancers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.annonc.2020.08.950","article-title":"811MO Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f\/u) from SOLO1","volume":"31","author":"Banerjee","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"102396","DOI":"10.1016\/j.ctrv.2022.102396","article-title":"GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee","volume":"107","author":"Woopen","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ijgc-2020-002023","article-title":"Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: A multicenter analysis","volume":"31","author":"Baum","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/AOG.0000000000000981","article-title":"Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer","volume":"126","author":"Cress","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2017.10.032","article-title":"Who are the long-term survivors of high grade serous ovarian cancer?","volume":"148","author":"Hoppenot","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/s41588-022-01230-9","article-title":"The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer","volume":"54","author":"Garsed","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ygyno.2018.11.007","article-title":"The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer","volume":"152","author":"Javellana","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Gynecologic Oncology Group Study. Prognostic factors for stage III epithelial ovarian cancer: A Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/IGC.0b013e31823eed2c","article-title":"Long-term clinical outcome of patients with recurrent epithelial ovarian carcinoma: Is it the same for each histological type?","volume":"22","author":"Kajiyama","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11764-015-0472-9","article-title":"Survivors of gynecologic malignancies: Impact of treatment on health and well-being","volume":"10","author":"Westin","year":"2016","journal-title":"J. Cancer Surviv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/IGC.0000000000001320","article-title":"The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors","volume":"28","author":"Matsuoka","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s00520-018-4510-9","article-title":"Presence of gastro-intestinal symptoms in ovarian cancer patients during survivorship: A cross-sectional study from the PROFILES registry","volume":"27","author":"Rietveld","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1188\/06.ONF.553-562","article-title":"Survivorship issues in ovarian cancer: A review","volume":"33","year":"2006","journal-title":"Oncol. Nurs. Forum"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00404-020-05896-6","article-title":"Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: A prospective study","volume":"303","author":"Giannattasio","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2016.03.010","article-title":"Characteristics of 10-year survivors of high-grade serous ovarian carcinoma","volume":"141","author":"Dao","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","article-title":"Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer","volume":"385","author":"Harter","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ygyno.2014.09.016","article-title":"Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registry","volume":"135","author":"Ezendam","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/IGC.0000000000000405","article-title":"Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: A retrospective study","volume":"25","author":"Hareyama","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11764-020-00973-w","article-title":"Cancer survivors referred to a long-term survivorship outpatient service within academic medical oncology: Descriptive study","volume":"15","author":"Gallego","year":"2021","journal-title":"J. Cancer Surviv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ogc.2018.10.002","article-title":"Gynecologic Cancer Survivorship","volume":"46","author":"Lokich","year":"2019","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1634\/theoncologist.2019-0184","article-title":"Survivorship Care Plans in Cancer: A Meta-Analysis and Systematic Review of Care Plan Outcomes","volume":"25","author":"Hill","year":"2020","journal-title":"Oncologist"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s11764-018-0713-9","article-title":"Survivorship care planning in gynecologic oncology-perspectives from patients, caregivers, and health care providers","volume":"12","author":"Thomas","year":"2018","journal-title":"J. Cancer Surviv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.14694\/EdBook_AM.2014.34.205","article-title":"Models of cancer survivorship health care: Moving forward","volume":"34","author":"Oeffinger","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/jnci\/djab034","article-title":"Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival","volume":"113","author":"Wenzel","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2010.02.027","article-title":"Surviving cervical cancer: Does health-related quality of life influence survival?","volume":"118","author":"Lim","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00520-019-05000-y","article-title":"The prognostic and predictive role of pain before systemic chemotherapy in recurrent ovarian cancer: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) of 1226 patients","volume":"28","author":"Woopen","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/annonc\/mdx229","article-title":"Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: An AURELIA substudy","volume":"28","author":"Roncolato","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.6004\/jnccn.2020.0037","article-title":"NCCN Guidelines Insights: Survivorship, Version 2.2020","volume":"18","author":"Denlinger","year":"2020","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2022.12.017","article-title":"Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG\/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors","volume":"170","author":"Thomson","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2015.10.002","article-title":"The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: A systematic review and meta-analysis","volume":"139","author":"Smits","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/ijgc-2018-000040","article-title":"Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: A population-based study in British Columbia, Canada","volume":"29","author":"Arora","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/ijgc-2020-002155","article-title":"Secondary malignancies in long-term ovarian cancer survivors: Results of the \u2018Carolin meets HANNA\u2019 study","volume":"31","author":"Woopen","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"107841","DOI":"10.1016\/j.maturitas.2023.107841","article-title":"Mediterranean diet for cancer prevention and survivorship","volume":"178","author":"Morgan","year":"2023","journal-title":"Maturitas"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2022.07.1941","article-title":"ESMO Expert Consensus Statements on Cancer Survivorship: Promoting high-quality survivorship care and research in Europe","volume":"33","author":"Masiero","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/annonc\/mdz074","article-title":"Long-term fatigue and quality of life among epithelial ovarian cancer survivors: A GINECO case\/control VIVROVAIRE I study","volume":"30","author":"Joly","year":"2019","journal-title":"Ann. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/22\/5428\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:23:29Z","timestamp":1760131409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/22\/5428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":41,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["cancers15225428"],"URL":"https:\/\/doi.org\/10.3390\/cancers15225428","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]}}}